secwatch.observer — SEC 8-K summary
======================================

Issuer:     BNB PLUS CORP. (BNBX)
CIK:        0000744452
Form:       8-K
Filed at:   2024-06-18T23:59:59+00:00
Accession:  0001104659-24-072876
Event type: regulatory
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Applied DNA Sciences believes it regained Nasdaq minimum equity compliance after $10.8M offering
--------------------------------------------------------------------------------

- Received Nasdaq deficiency notice May 16, 2024 for stockholders' equity of -$175,385 vs. $2.5M minimum requirement.
- Closed public offering May 29, 2024, raising approximately $10.8M in net proceeds from common stock and warrants.
- Company now believes it meets Nasdaq Listing Rule 5550(b)(1) stockholders' equity requirement.
- Nasdaq will continue monitoring; non-compliance at next periodic report may lead to delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/744452/000110465924072876/0001104659-24-072876-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/744452/000110465924072876/tm2417556d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-072876

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer